HALEIGH DENAME: Open Payments
NPI 1043876998 · BETHEL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 48 payments from 12 companies in 2025. Trend: 2023 $509 · 2024 $723 · 2025 $1,130
Food & beverage: $1,075Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $260 |
| Janssen Biotech, Inc. | 9 | $243 |
| UCB, Inc. | 5 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| PFIZER INC. | 5 | $102 |
| GENZYME CORPORATION | 2 | $66 |
| LEO Pharma Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
Products named: TREMFYA, RINVOQ, Bimzelx, SKYRIZI, CIBINQO, DUPIXENT, ADBRY, Rhapsido.
Industry payments across CT — which companies pay providers there.
